Taro Pharmaceuticals U.S.A., Inc. recalls Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2
Recalled February 10, 2021 · FDA recall D-0246-2021 · Taro Pharmaceuticals U.S.A
Hazard
CGMP deviations. · FDA Class II
Units
44,256 bottles
Sold at
Nationwide
Description
CGMP deviations.
Product
Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1
Manufacturer(s)
Taro Pharmaceuticals U.S.A., Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →